Peter Lim to inject healthcare assets into Rowsley
Singapore
REAL estate and investment firm Rowsley said on Tuesday night that controlling shareholder, Singapore billionaire Peter Lim, will be injecting his 100 per cent stake in Thomson Medical Pte Ltd and 70.36 per cent stake in Bursa Malaysia-listed TMC Life Sciences (TMCLS) into the firm.
The proposed acquisitions are valued at up to S$1.9 billion, and will be financed through up to 25.3 billion consideration shares issued by Rowsley to Mr Lim at S$0.075 a share.
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Companies & Markets
TikTok tells advertisers: ‘We are not backing down’
EV automakers get reprieve in US tax credit rules
Nomura, Mizuho face losses on All Blue fund’s failed trades
Stablecoin Tether steps up monitoring in bid to combat illicit finance
HSBC asked by US$890 billion investor group to set energy goal
BHP’s biggest rivals sit on the sidelines of Anglo M&A drama